Jay D Gerber

This inventor holds 7 USPTO granted patents and 8 published patent applications, plus 1 CIPO patent. Top assignees: Advanced Bioadjuvants LLC, Norden Laboratories, Inc., American Cyanamid Company. Active years: 1987-2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jay D Gerber. Retrieved from https://idiyas.com/inventor/jay-d-gerber

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7 (Patent Applications = 8)

% Patents Active = 85.7

CIPO Patents = 1 (Patent Applications = 3)

Average Co-Inventor Count = 1.2

ph-index = 4

Forward Citations = 109(Granted Patents)

Location History:

Omaha, NE (US) (2011)
Lincoln, NE (US) (1987 - 2013)

Company Filing History:

3 out of 3

Advanced Bioadjuvants LLC

patents

2 out of 19

Norden Laboratories, Inc.

patents

1 out of 3,580

American Cyanamid Company

Years Active: 1987-2013

Loading Chart...

7 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8501221 - Methods for preparing and delivering adjuvant compositions (2013-08-06),

2. 7879333 - Methods for preparing and delivering adjuvant compositions (2011-02-01),

3. 6676958 - Adjuvant composition for mucosal and injection delivered vaccines (2004-01-13),

4. 6113916 - Method of enhancing cell mediated immune responses (2000-09-05),

5. 5667785 - Vaccine for protection of cats against feline infectious peritonitis (1997-09-16),

6. 4806350 - Vaccine formulation (1989-02-21),

7. 4675176 - Moraxella bovis protease vaccine (1987-06-23),

Title: The Innovative Contributions of Jay D Gerber

Introduction

Jay D Gerber is a notable inventor based in Lincoln, NE (US), recognized for his significant contributions to the field of vaccine adjuvants. With a total of seven patents to his name, Gerber has made strides in enhancing vaccine efficacy through innovative methods.

Latest Patents

Among his latest patents, Gerber has developed methods for preparing and delivering adjuvant compositions. These methods involve the use of lecithin and a polymer, preferably polyacrylic acid-based. The delivery method focuses on administering a vaccine, which includes an antigen and the adjuvant, to a mucosal surface. This innovative approach aims to improve the effectiveness of vaccines by optimizing the delivery of adjuvants.

Career Highlights

Throughout his career, Gerber has worked with various companies, including Advanced Bioadjuvants LLC and Norden Laboratories, Inc. His work in these organizations has contributed to advancements in vaccine technology and the development of new adjuvant formulations.

Collaborations

Gerber has collaborated with notable professionals in his field, including Balbir S Bhogal and Krishnaswamy Iyengar Dayalu. These collaborations have further enriched his research and development efforts in vaccine adjuvants.

Conclusion

Jay D Gerber's innovative work in vaccine adjuvants showcases his commitment to improving public health through scientific advancements. His contributions continue to influence the field of immunology and vaccine development.

Profile summary based on public USPTO records.